Simulating therapeutics using multiscale models of the VEGF receptor system in cancer

FM Gabhann, MO Stefanini, AS Popel - Modeling tumor vasculature …, 2012 - Springer
Abstract In recent years, Judah Folkman's vision of anticancer therapeutics based on
inhibiting angiogenesis pathways has begun to be realized. In particular, antibodies …
被引用次数：6 相关文章
[PDF] researchgate.net

[PDF][PDF] Simulating Therapeutics Using Multiscale Models of the VEGF Receptor System in Cancer

F Mac Gabhann, MO Stefanini, AS Popel - 2012 - researchgate.net
Exploration of antiangiogenic cancer therapeutics began when Dr. Judah Folkman
postulated that tumors must depend on angiogenesis (neovascularization) for their growth …

Simulating therapeutics using multiscale models of the VEGF receptor system in cancer

F Mac Gabhann, MO Stefanini… - … Molecular, Cellular, and …, 2012 - pure.johnshopkins.edu
Abstract In recent years, Judah Folkman's vision of anticancer therapeutics based on
inhibiting angiogenesis pathways has begun to be realized. In particular, antibodies …

Simulating Therapeutics Using Multiscale Models of the VEGF Receptor System in Cancer

F Mac Gabhann, MO Stefanini… - … : Molecular, Cellular, and …, 2011 - books.google.com
Exploration of antiangiogenic cancer therapeutics began when Dr. Judah Folkman
postulated that tumors must depend on angiogenesis (neovascularization) for their growth …

Simulating Therapeutics Using Multiscale Models of the VEGF Receptor System in Cancer

F Mac Gabhann, MO Stefanini, AS Popel - 2012 - Springer
Exploration of antiangiogenic cancer therapeutics began when Dr. Judah Folkman
postulated that tumors must depend on angiogenesis (neovascularization) for their growth …

[引用][C] Simulating Therapeutics Using Multiscale Models of the VEGF Receptor System in Cancer

FM Gabhann, MO Stefanini, AS Popel - Modeling Tumor Vasculature, 2012 - Springer